Prevalence of actionable pharmacogenomic variants in Brazilian patients with cancer.

Schuch JB, Botton MR, De Baumont AC, Curzel G, Cadore NA, Bordignon C, Rosa ML, Vasconcellos VF, Barros LAR, Souza CP, Barra WF, Louzeiro DLC, Notari A, de Menezes JJ, Liedke PER, Bertollo GA, Gongora ABL, Ascenco HG, Kowalski-Neto E, Oppermann CP, Werutsky G, Santos EM, Brandão FS, Freitas-Junior R, Nogueira-Rodrigues A, Mancini ALC, Bessel M, Macedo GS, Rosa DD

Open source

DOI: 10.3389/fphar.2026.1736887
Published: 2026
Container: Frontiers in pharmacology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1736887,
  title = {Prevalence of actionable pharmacogenomic variants in Brazilian patients with cancer.},
  author = {Schuch JB and Botton MR and De Baumont AC and Curzel G and Cadore NA and Bordignon C and Rosa ML and Vasconcellos VF and Barros LAR and Souza CP and Barra WF and Louzeiro DLC and Notari A and de Menezes JJ and Liedke PER and Bertollo GA and Gongora ABL and Ascenco HG and Kowalski-Neto E and Oppermann CP and Werutsky G and Santos EM and Brandão FS and Freitas-Junior R and Nogueira-Rodrigues A and Mancini ALC and Bessel M and Macedo GS and Rosa DD},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1736887},
  url = {https://doi.org/10.3389/fphar.2026.1736887}
}

RIS

TY  - JOUR
TI  - Prevalence of actionable pharmacogenomic variants in Brazilian patients with cancer.
AU  - Schuch JB
AU  - Botton MR
AU  - De Baumont AC
AU  - Curzel G
AU  - Cadore NA
AU  - Bordignon C
AU  - Rosa ML
AU  - Vasconcellos VF
AU  - Barros LAR
AU  - Souza CP
AU  - Barra WF
AU  - Louzeiro DLC
AU  - Notari A
AU  - de Menezes JJ
AU  - Liedke PER
AU  - Bertollo GA
AU  - Gongora ABL
AU  - Ascenco HG
AU  - Kowalski-Neto E
AU  - Oppermann CP
AU  - Werutsky G
AU  - Santos EM
AU  - Brandão FS
AU  - Freitas-Junior R
AU  - Nogueira-Rodrigues A
AU  - Mancini ALC
AU  - Bessel M
AU  - Macedo GS
AU  - Rosa DD
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1736887
UR  - https://doi.org/10.3389/fphar.2026.1736887
ER  -

APA

JB, S., MR, B., AC, D. B., G, C., NA, C., C, B., ML, R., VF, V., LAR, B., CP, S., WF, B., DLC, L., A, N., JJ, D. M., PER, L., GA, B., ABL, G., HG, A., E, K., CP, O., G, W., EM, S., FS, B., R, F., A, N., ALC, M., M, B., GS, M., & DD, R. (2026). Prevalence of actionable pharmacogenomic variants in Brazilian patients with cancer.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1736887

Source records

pubmed · retrieved 2026-09-27T13:06:22.099Z